Sanofi

Sanofi to Step Up Development of New Diabetes Device

U.S. Launch of Novo's New Insulin Faces Long Delay

Biogen Wins EU Backing for Big New MS Drug Hope

French Drugs Market to Shrink Further in 2013

Antibiotics Crisis Prompts Rethink on Risks, Rewards

Drugmakers Eye Africa's Middle Classes as Next Growth Market

Regeneron Says Sanofi to Boost Stake in its Shares

Amgen Biosimilar Push Takes Aim at Blockbusters

Buyers Eye Multibillion Deal for Brazilian Drugmaker

Patent Expiries Delay Sanofi's Return to Growth

Drugmakers, Academics Pool R&D in $265 Million EU Project

Zoetis IPO Prices at $26; Largest US Deal Since Facebook

FDA Head, Company CEOs Cheer Bumper Haul of New Drugs

U.S. Government Investment Gives Flu Vaccines a Shot in the Arm

Roche Says US Allows it to Tap Adult Tamiflu Reserves

Drug Industry Bets on New Blockbusters in 2013

Bio-Process Systems Alliance Elects Leadership Team for 2013-2015

Sanofi Appoints Dr. Gary J. Nabel as Chairman of the Strategic Development and Scientific Advisory Council

Top-Selling Drugs for Ultra-Rare Diseases

Entering the Age of the $1 Million Medicine

US FDA New Drug Approvals Hit 16-Year High in 2012

Number of New Drugs Picks Up in Europe and U.S.

EU Agency Rejects Sanofi, Isis Cholesterol Drug

More Pressure to Justify Cost of Cancer Drugs Versus Benefits

Bayer Diabetes Unit Sale Unlikely

Drug Industry Treading Water on R&D Productivity

Human Stool Treatment Upends Race to Treat Colon Germ

GSK and J&J Lead Rivals in Drug Access for Poor

German Research Points Way to Faster Flu Vaccines

Topics • Technology

Pharma vs. the World

Sanofi Lets Genzyme's Biotech Culture Call the Shots

Sanofi Draws Fire Over Cost of MS Drug Lemtrada

Strong Refining Margins Boost Total Q3

Sanofi Sees Relief from Patent Loss Pain

FDA Reviewers Spot Safety Concerns With Sanofi, Isis Lipid Drug

136 more articles

Top-Feature

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Predictive Simulation in Pharma Production

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Article

The State of the US Specialty Chemicals Industry

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.